Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Exploring the Association between Delirium and Malnutrition in COVID-19 Survivors: A Geriatric Perspective.
Nutrients. 2023 Nov 9;15(22):4727. doi: 10.3390/nu15224727.
Nutrients. 2023.
PMID: 38004121
Free PMC article.
Reduced Dose of Abiraterone Acetate with Concomitant Low-dose Prednisone in the Treatment of ≥ 85 Year-old Patients with Advanced Castrate-resistant Prostate Cancer.
Petrioli R, Francini E, Fiaschi AI, Laera L, Miano ST, De Rubertis G, Roviello G.
Petrioli R, et al. Among authors: de rubertis g.
Anticancer Res. 2015 May;35(5):3097-102.
Anticancer Res. 2015.
PMID: 25964601
Item in Clipboard
Rechallenge of docetaxel combined with epirubicin given on a weekly schedule in advanced castration-resistant prostate cancer patients previously exposed to docetaxel and abiraterone acetate: a single-institution experience.
Petrioli R, Roviello G, Fiaschi AI, Laera L, Miano ST, De Rubertis G, Barbanti G, Bianco V, Brozzetti S, Francini E.
Petrioli R, et al. Among authors: de rubertis g.
Med Oncol. 2015 Mar;32(3):52. doi: 10.1007/s12032-015-0485-2. Epub 2015 Jan 31.
Med Oncol. 2015.
PMID: 25636506
Clinical Trial.
Item in Clipboard
Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: a randomised phase II study.
Petrioli R, Pascucci A, Conca R, Chiriacò G, Francini E, Bargagli G, Fiaschi AI, Manganelli A, De Rubertis G, Barbanti G, Ponchietti R, Francini G.
Petrioli R, et al. Among authors: de rubertis g.
Br J Cancer. 2011 Feb 15;104(4):613-9. doi: 10.1038/bjc.2011.5. Epub 2011 Feb 1.
Br J Cancer. 2011.
PMID: 21285986
Free PMC article.
Clinical Trial.
Item in Clipboard
Capecitabine as third-line treatment in patients with metastatic renal cell carcinoma after failing immunotherapy.
Petrioli R, Paolelli L, Francini E, Marsili S, Pascucci A, Sciandivasci A, de Rubertis G, Barbanti G, Manganelli A, Salvestrini F, Francini G.
Petrioli R, et al. Among authors: de rubertis g.
Anticancer Drugs. 2007 Aug;18(7):817-20. doi: 10.1097/CAD.0b013e3280a02f17.
Anticancer Drugs. 2007.
PMID: 17581304
Clinical Trial.
Item in Clipboard
Weekly high-dose calcitriol and docetaxel in patients with metastatic hormone-refractory prostate cancer previously exposed to docetaxel.
Petrioli R, Pascucci A, Francini E, Marsili S, Sciandivasci A, De Rubertis G, Barbanti G, Manganelli A, Salvestrini F, Francini G.
Petrioli R, et al. Among authors: de rubertis g.
BJU Int. 2007 Oct;100(4):775-9. doi: 10.1111/j.1464-410X.2007.07019.x. Epub 2007 May 29.
BJU Int. 2007.
PMID: 17535276
Item in Clipboard
A genetic circuit amplifier: design and simulation.
De Rubertis G, Davies SW.
De Rubertis G, et al.
IEEE Trans Nanobioscience. 2003 Dec;2(4):239-46. doi: 10.1109/tnb.2003.820283.
IEEE Trans Nanobioscience. 2003.
PMID: 15376914
Item in Clipboard
Cite
Cite